載入...
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy
IMPORTANCE: Although IgA nephropathy (IgAN) is the most common glomerulonephritis in the world, there is no validated tool to predict disease progression. This limits patient-specific risk stratification and treatment decisions, clinical trial recruitment, and biomarker validation. OBJECTIVE: To der...
Na minha lista:
| 發表在: | JAMA Intern Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Medical Association
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6583088/ https://ncbi.nlm.nih.gov/pubmed/30980653 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2019.0600 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|